Lyka Labs Limited Cash Flow Conversion Efficiency
Lyka Labs Limited cash flow conversion efficiency. Based on the latest financial reports, Lyka Labs Limited (LYKALABS) has a cash flow conversion efficiency ratio of 0.135x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs136.84 Million ≈ $1.48 Million USD) by net assets (Rs1.01 Billion ≈ $10.96 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Lyka Labs Limited (2005–2025)
Cash flow conversion efficiency of Lyka Labs Limited from 2005 to 2025. This chart illustrates how Lyka Labs Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View LYKALABS share price today for real-time trading data and today's change.
Lyka Labs Limited Cash Flow Conversion Ratio Explained
Lyka Labs Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Lyka Labs Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Lyka Labs Limited ranked by their cash flow conversion efficiency. Also see LYKALABS market cap overview for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Serinus Energy Inc.
WAR:SEN
|
0.002x |
|
Bragg Gaming Group Inc
TO:BRAG
|
0.063x |
|
Barinthus Biotherapeutics plc
NASDAQ:BRNS
|
-0.127x |
|
ENERGIA IN.Y DES. EO 025
F:F63
|
N/A |
|
Verimatrix
PA:VMX
|
-0.012x |
|
AppSpotr AB
ST:APTR
|
-0.030x |
|
Gesundheitswelt Chiemgau AG
MU:JTH
|
N/A |
|
Skyline Builders Group Holding Limited
NASDAQ:KAZR
|
-0.016x |
Annual Cash Flow Conversion Efficiency for Lyka Labs Limited (2005–2025)
The table below shows the annual cash flow conversion efficiency of Lyka Labs Limited from 2005 to 2025. Review LYKALABS free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs1.04 Billion ≈ $11.20 Million |
Rs18.99 Million ≈ $205.41K |
0.018x | -29.41% |
| 2024-03-31 | Rs682.65 Million ≈ $7.38 Million |
Rs17.73 Million ≈ $191.78K |
0.026x | -86.75% |
| 2023-03-31 | Rs456.71 Million ≈ $4.94 Million |
Rs89.53 Million ≈ $968.19K |
0.196x | -96.66% |
| 2022-03-31 | Rs134.91 Million ≈ $1.46 Million |
Rs792.46 Million ≈ $8.57 Million |
5.874x | +1772.76% |
| 2021-03-31 | Rs-250.93 Million ≈ $-2.71 Million |
Rs88.11 Million ≈ $952.93K |
-0.351x | +0.32% |
| 2020-03-31 | Rs-151.11 Million ≈ $-1.63 Million |
Rs53.23 Million ≈ $575.71K |
-0.352x | -160.45% |
| 2019-03-31 | Rs457.59 Million ≈ $4.95 Million |
Rs266.66 Million ≈ $2.88 Million |
0.583x | +211.82% |
| 2018-03-31 | Rs582.36 Million ≈ $6.30 Million |
Rs108.83 Million ≈ $1.18 Million |
0.187x | -74.93% |
| 2017-03-31 | Rs421.01 Million ≈ $4.55 Million |
Rs313.81 Million ≈ $3.39 Million |
0.745x | +1938.60% |
| 2016-03-31 | Rs491.54 Million ≈ $5.32 Million |
Rs-19.93 Million ≈ $-215.50K |
-0.041x | -107.11% |
| 2015-03-31 | Rs465.71 Million ≈ $5.04 Million |
Rs265.40 Million ≈ $2.87 Million |
0.570x | -64.17% |
| 2014-03-31 | Rs560.17 Million ≈ $6.06 Million |
Rs890.99 Million ≈ $9.64 Million |
1.591x | +914.04% |
| 2013-03-31 | Rs697.62 Million ≈ $7.54 Million |
Rs109.43 Million ≈ $1.18 Million |
0.157x | +154.43% |
| 2012-03-31 | Rs755.73 Million ≈ $8.17 Million |
Rs-217.78 Million ≈ $-2.36 Million |
-0.288x | -380.89% |
| 2010-03-31 | Rs1.43 Billion ≈ $15.41 Million |
Rs146.23 Million ≈ $1.58 Million |
0.103x | +129.68% |
| 2008-03-31 | Rs780.73 Million ≈ $8.44 Million |
Rs-269.87 Million ≈ $-2.92 Million |
-0.346x | -33.00% |
| 2007-03-31 | Rs460.74 Million ≈ $4.98 Million |
Rs-119.75 Million ≈ $-1.29 Million |
-0.260x | -136.00% |
| 2005-03-31 | Rs286.25 Million ≈ $3.10 Million |
Rs206.68 Million ≈ $2.24 Million |
0.722x | -- |
About Lyka Labs Limited
Lyka Labs Limited, a pharmaceutical company, develops, manufactures, and markets pharmaceutical formulations and active pharmaceutical ingredients in India. The company manufactures and sells various formulations, including emollient, topical steroid, antifungal agent, topical anti-bacterial, acne management, dermatological formulation, pain killer, anti-aging, cleansing lotion, hair care, anti-d… Read more